Rebif 8.8 und 22 RebiDose
Rebif 8.8 und 22 RebiDose is a medicine authorised by Swissmedic under authorisation number 62067. The authorisation holder is Merck (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 February 2012 and the authorisation is valid without a time limit. ATC code L03AB07 places the medicine in the group Immunostimulants.
| Authorisation number | 62067 |
|---|---|
| Name | Rebif 8.8 und 22 RebiDose |
| Full name | Rebif 8.8 und 22 RebiDose, Injektionslösung im Fertigpen |
| Authorisation holder | Merck (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L03AB07 |
| First authorisation | 13 February 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rebif 8.8 und 22 RebiDose, Injektionslösung im Fertigpen | B | 13 February 2012 |
| 2 | Rebif 22 RebiDose, Injektionslösung im Fertigpen | B | 13 February 2012 |
| 3 | Rebif 44 RebiDose, Injektionslösung im Fertigpen | B | 13 February 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 6 + 6 | Injektor(en), vorgefüllt/Pen | L03AB07 | 01.99.0. | B |
| 4 | 12 | Injektor(en), vorgefüllt/Pen | L03AB07 | 01.99.0. | B |
| 7 | 12 | Injektor(en), vorgefüllt/Pen | L03AB07 | 01.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rebif 8.8 und 22 RebiDose authorised in Switzerland?
Yes. Rebif 8.8 und 22 RebiDose is authorised by Swissmedic under authorisation number 62067, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rebif 8.8 und 22 RebiDose have?
Rebif 8.8 und 22 RebiDose is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rebif 8.8 und 22 RebiDose?
The authorisation holder is Merck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.